Enzyvant, a commercial-stage biotech firm with a focus on regenerative medicines for rare diseases, has signed a lease for a new manufacturing facility in North Carolina's Research Triangle Park.
RELATED ARTICLES
This news story is available exclusively to CoStar subscribers.
Watch the video to learn how you can access industry leading CRE news and the data analytics you need to drive success.
This news story is available exclusively to CoStar subscribers.
Ready to Learn More?
Sign Up For a Personalized Demo.
Sign Up For a Demo To Learn More.
Already A Subscriber? Sign In
IN THIS ARTICLE
- Properties
- Southport 4
101 Southcenter Ct, Morrisville, NC
- Companies
- Trinity Capital Advisors, LLC
Professional, Scientific, and Technical Services